Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

被引：0
|
作者：
Umesh Gangishetti
J. Christina Howell
Richard J. Perrin
Natalia Louneva
Kelly D. Watts
Alexander Kollhoff
Murray Grossman
David A. Wolk
Leslie M. Shaw
John C. Morris
John Q. Trojanowski
Anne M. Fagan
Steven E. Arnold
William T. Hu
机构：
[1] Emory University,Department of Neurology
[2] Emory University,Department of Alzheimer’s Disease Research Center
[3] Washington University,Knight Alzheimer’s Disease Research Center
[4] Washington University,Department of Pathology
[5] Washington University,Department of Neurology
[6] University of Pennsylvania,Penn Memory Center
[7] University of Pennsylvania,Center for Neurodegenerative Disease Research
[8] University of Pennsylvania,Penn FTD Center
[9] University of Pennsylvania,Department of Neurology
[10] University of Pennsylvania,Department of Pathology and Laboratory Medicine
[11] Present Address: Massachusetts General Hospital,undefined
来源：
Alzheimer's Research & Therapy | / 10卷
关键词：
Biomarkers; Fatty acid binding protein; Interleukin-10; Mild cognitive impairment; Neurofilament light chain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity
    Samgard, Kaisa
    Zetterberg, Henrik
    Blennow, Kaj
    Hansson, Oskar
    Minthon, Lennart
    Londos, Elisabet
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 25 (04) : 403 - 410
  • [42] Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
    Mattsson, Niklas
    Insel, Philip S.
    Palmqvist, Sebastian
    Portelius, Erik
    Zetterberg, Henrik
    Weiner, Michael
    Blennow, Kai
    Hansson, Oskar
    EMBO MOLECULAR MEDICINE, 2016, 8 (10) : 1184 - 1196
  • [43] Cerebrospinal fluid amyloidβ42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia
    de Jong, Danielle
    Jansen, Rene W. M. M.
    Kremer, Berry P. H.
    Verbeek, Marcel M.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2006, 61 (07): : 755 - 758
  • [44] Interactions between Amyloid-β and Tau in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Alzheimer's Disease
    Kristofikova, Zdena
    Ricny, Jan
    Kolarova, Michaela
    Vyhnalek, Martin
    Hort, Jakub
    Laczo, Jan
    Sirova, Jana
    Ripova, Daniela
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S91 - S98
  • [45] Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau
    Lafirdeen, Aysha S. Mohamed
    Cognat, Emmanuel
    Sabia, Severine
    Hourregue, Claire
    Lilamand, Matthieu
    Dugravot, Aline
    Bouaziz-Amar, Elodie
    Laplanche, Jean-Louis
    Hugon, Jacques
    Singh-Manoux, Archana
    Paquet, Claire
    Dumurgier, Julien
    PLOS ONE, 2019, 14 (05):
  • [46] Hyperphosphorylated Tau Protein and β-Amyloid in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Depression. Preliminary Findings
    da Silva, Taylor Reis, Jr.
    Brandao, Carlos Otavio
    Laks, Jerson
    NEUROLOGY, 2011, 76 (09) : A663 - A663
  • [47] NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer's Disease
    Garcia-Escobar, Greta
    Puig-Pijoan, Albert
    Puente-Periz, Victor
    Fernandez-Lebrero, Aida
    Maria Manero, Rosa
    Navalpotro-Gomez, Irene
    Suarez-Calvet, Marc
    Grau-Rivera, Oriol
    Contador-Munana, Jose
    Cascales-Lahoz, Diego
    Duran-Jorda, Xavier
    Boltes, Nuncia
    Claustre Pont-Sunyer, Maria
    Ortiz-Gil, Jordi
    Carrillo-Molina, Sara
    Dolores Lopez-Villegas, Maria
    Teresa Abellan-Vidal, Maria
    Isabel Martinez-Casamitjana, Maria
    Jose Hernandez-Sanchez, Juan
    Padros-Fluvia, Anna
    Pena-Casanova, Jordi
    Sanchez-Benavides, Gonzalo
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (04) : 1303 - 1321
  • [48] Borderline concentrations of a cerebrospinal fluid triplet of tau proteins and beta-amyloid 42 in the diagnosis of Alzheimer's disease and other neurodegenerative dementias
    Bartos, A.
    Bruzova, M.
    Fialova, L.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (06) : 511 - 513
  • [49] Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease?
    McLimans, Kelsey E.
    Clark, Bridget E.
    Plagman, Alexandra
    Pappas, Colleen
    Klinedinst, Brandon
    Anatharam, Vellareddy
    Kanthasamy, Anumantha
    Willette, Auriel A.
    ANTIOXIDANTS & REDOX SIGNALING, 2019, 31 (08) : 572 - 578
  • [50] Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement
    Musiek, Erik S.
    Holtzman, David M.
    CURRENT OPINION IN NEUROLOGY, 2012, 25 (06) : 715 - 720
12345